重症急性胰腺炎早期免疫抑制的研究进展

doi:10.3877/cma.j.issn.2096-1537.2023.03.009

重症急性胰腺炎（SAP）在ICU临床管理中具有诸多挑战，病情严重程度往往取决于早期炎症反应，约30%的SAP患者因严重的细菌感染或器官衰竭而死亡。研究显示SAP患者早期就已发生全身免疫抑制和肠道黏膜免疫损伤，可导致感染性坏死性胰腺炎、菌血症等感染并发症，与病程加长，病死率增加相关。然而临床上经常忽视SAP早期免疫抑制，缺少被证实安全、有效的免疫干预措施，导致最佳治疗时间错过和感染相关并发症增加。本文总结近年来SAP早期免疫抑制的研究热点，为及时识别免疫抑制和免疫干预研究提供参考，减少病程早期和后期的感染并发症，改善患者预后。

关键词: 重症急性胰腺炎, 免疫抑制, 黏膜免疫

Severe acute pancreatitis (SAP) has many challenges in the clinical management of ICU. The severity and prognosis of the disease often depend on the early inflammatory reaction. About 30% of patients die of severe bacterial infection or organ failure. Studies have shown that SAP patients have suffered from systemic immunosuppression and intestinal immune barrier damage in the early course of disease, which may lead to infectious complications such as infectious necrotizing pancreatitis and bacteremia, and is associated with a longer disease course and increased mortality. However, the early immunosuppression of SAP is often ignored in clinic, and the optimal time for treatment is missed, which leads to progressive aggravation of secondary infection. This article summarizes the researches of early immunosuppression SAP in recent years to provide reference for early identification of immunosuppression and timely immune intervention to reduce the infection complications at the early and late stages of the disease course and improve the prognosis of patients.

Key words: Severe acute pancreatitis, Immunosuppression, Mucosal immunity

1	Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis [J]. Lancet, 2020, 396(10252): 726-734.
2	Zhuang Q, Huang L, Zeng Y, et al. Dynamic monitoring of immunoinflammatory response identifies immunoswitching characteristics of severe acute pancreatitis in rats [J]. Front Immunol, 2022, 13: 876168.
3	Yovtchev Y, Halacheva K, Dimitrov E, et al. Is it time for routinely tracking of early immunosuppression in tracking and prognosing patients with acute pancreatitis [J]. Pancreatology, 2018, 18(4): S97.
4	Sendler M, van den Brandt C, Glaubitz J, et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis [J]. Gastroenterology, 2020, 158(1): 253-269.
5	Sharma D, Jakkampudi A, Reddy R, et al. Association of systemic inflammatory and anti-inflammatory responses with adverse outcomes in acute pancreatitis: preliminary results of an ongoing study [J]. Dig Dis Sci, 2017, 62(12): 3468-3478.
6	Vaz J, Akbarshahi H, Andersson R. Controversial role of Toll-like receptors in acute pancreatitis [J]. World J Gastroenterol, 2013, 19(5):616-30.
7	Li J, Pan X, Yang J, et al. Enteral virus depletion modulates experimental acute pancreatitis via toll-like receptor 9 signaling [J]. Biochem Pharmacol, 2020, 171: 113710.
8	Shen Y, Cui NQ. Clinical observation of immunity in patients with secondary infection from severe acute pancreatitis [J]. Inflamm Res, 2012, 61(7): 743-748.
9	Zhao Q, Wei Y, Pandol SJ, et al. STING signaling promotes inflammation in experimental acute pancreatitis [J]. Gastroenterology, 2018, 154(6): 1822-1835.
10	Wu J, Chen YJ, Dobbs N, et al. STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death [J]. J Exp Med, 2019, 216(4): 867-883.
11	Zhu Y, He C, Li X, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice [J]. J Gastroenterol, 2019, 54(4): 347-358.
12	Sendler M, Wilden A, Glaubitz J, et al. Immunosuppression during severe acute pancreatitis is associated with a dramatic shift in intestinal microbiota composition and infected necrosis [J]. Pancreatology, 2020, 20(1): S24.
13	Li XY, He C, Zhu Y, et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis [J]. World J Gastroenterol, 2020, 26(18): 2187-2193.
14	Zou M, Yang Z, Fan Y, et al. Gut microbiota on admission as predictive biomarker for acute necrotizing pancreatitis [J]. Front Immunol, 2022, 13: 988326.
15	Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial [J]. Lancet, 2008, 371(9613): 651-659.
16	Dang SC, Zhang JX, Qu JG, et al. Dynamic changes of IL-2/IL-10, sFas and expression of Fas in intestinal mucosa in rats with acute necrotizing pancreatitis [J]. World J Gastroenterol, 2008, 14(14): 2246-2250.
17	van den Berg FF, van Dalen D, Hyoju SK, et al. Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate [J]. Gut, 2021, 70(5): 915-927.
18	Li H, Zhao L, Wang Y, et al. Roles, detection, and visualization of neutrophil extracellular traps in acute pancreatitis [J]. Front Immunol, 2022, 13: 974821.
19	Zhou L, Chen J, Mu G, et al. Heparin-binding protein (HBP) worsens the severity of pancreatic necrosis via up-regulated M1 macrophages activation in acute pancreatitis mouse models [J]. Bioengineered, 2021, 12(2): 11978-11986.
20	Huang Y, Xiao J, Cai T, et al. Immature granulocytes: a novel biomarker of acute respiratory distress syndrome in patients with acute pancreatitis [J]. J Crit Care, 2019, 50: 303-308.
21	Tremblay JA, Peron F, Kreitmann L, et al. A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score [J]. Ann Intensive Care, 2022, 12(1):76.
22	Zhang R, Shi J, Zhang R, et al. Expanded CD14^hiCD16^- immunosuppressive monocytes predict disease severity in patients with acute pancreatitis [J]. J Immunol, 2019, 202(9): 2578-2584.
23	Pan T, Zhou T, Li L, et al. Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis [J]. Crit Care, 2017, 21(1): 186.
24	Chen Y, Li M, Liu J, et al. sPD-L1 Expression is associated with immunosuppression and infectious complications in patients with acute pancreatitis [J]. Scand J Immunol, 2017, 86(2): 100-106.
25	Xiao HL, Wang GX, Wang Y, et al. Dynamic blood presepsin levels are associated with severity and outcome of acute pancreatitis: a prospective cohort study [J]. World J Gastroenterol, 2022, 28(35): 5203-5216.
26	Ding L, Wan M, Wang D, et al. Myeloid-derived suppressor cells in patients with acute pancreatitis with increased inhibitory function [J]. Front Immunol, 2022, 13: 840620.
27	Zhao Z, Shen J, Zhang D, et al. The prognostic role of peripheral lymphocyte subsets in patients with acute pancreatitis [J]. Am J Med Sci, 2019, 357(3): 242-246.
28	Fonteh P, Smith M, Brand M. Adaptive immune cell dysregulation and role in acute pancreatitis disease progression and treatment [J]. Arch Immunol Ther Exp, 2018, 66 (3): 199-209.
29	Wei X, Yao W, Li H, et al. B and NK cells closely correlate with the condition of patients with acute pancreatitis [J]. Gastroenterol Res Pract, 2019, 2019: 7568410.
30	Bedrosian AS, Nguyen AH, Hackman M, et al. Dendritic cells promote pancreatic viability in mice with acute pancreatitis [J]. Gastroenterology, 2011, 141(5): 1915-1926. e1-e14.
31	Zhou J, Chen W, Liu Y, et al. Trajectories of lymphocyte counts in the early phase of acute pancreatitis are associated with infected pancreatic necrosis [J]. Clin Transl Gastroenterol, 2021, 12(9): e00405.
32	Ding L, Yang Y, Li H, et al. Circulating lymphocyte subsets induce secondary infection in acute pancreatitis [J]. Front Cell Infect Microbiol, 2020, 10: 128.
33	Damoiseaux J. The IL-2 - IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor [J]. Clin Immunol, 2020, 218: 108515.
34	Bao Y, Ge W. Correlation between serum levels of PTX-3, SIL-2R, inflammatory markers, and APACHE Ⅱ scores in patients with severe acute pancreatitis [J]. Medicine (Baltimore), 2022, 101(43): e31252.
35	Uehara S, Gothoh K, Handa H, et al. Immune function in patients with acute pancreatitis [J]. Gastroenterol Hepatol, 2003, 18(4): 363-370.
36	Yu X, Pan Y, Fei Q, et al. Serum soluble PD-1 plays a role in predicting infection complications in patients with acute pancreatitis [J]. Immun Inflamm Dis, 2021, 9(1): 310-318.
37	Qin Y, Pinhu L, You Y, et al. The role of Fas expression on the occurrence of immunosuppression in severe acute pancreatitis [J]. Dig Dis Sci, 2013, 58(11): 3300-3307.
38	Sharma M, Sachdev V, Singh N, et al. Alterations in intestinal permeability and endotoxemia in severe acute pancreatitis [J]. Trop Gastroenterol, 2012, 33(1): 45-50.
39	Qiu Z, Yu P, Bai B, et al. Regulatory B10 cells play a protective role in severe acute pancreatitis [J]. Inflamm Res, 2016, 65(8): 647-654.

[1]	杨晶, 高青. 重症急性胰腺炎继发脓毒症的危险因素分析[J]. 中华危重症医学杂志(电子版), 2023, 16(02): 105-110.
[2]	马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[3]	黄翠君, 张喜玲, 刘思嘉, 刘云建. 重症急性胰腺炎营养支持治疗研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(05): 385-390.
[4]	张原, 李小龙, 王亚鹏. 胰腺癌中ANGPTL2蛋白与免疫抑制细胞浸润的关系及临床意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 145-148.
[5]	钟文涛, 赵阳, 沈晓菲, 杜峻峰. 自噬在脓毒症中的作用及靶向治疗研究进展[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 221-225.
[6]	中国器官移植发展基金会器官移植受者健康管理专家委员会, 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 国家肝脏移植质控中心. 肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(04): 193-204.
[7]	中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[8]	巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[9]	刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正. 新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究[J]. 中华移植杂志(电子版), 2023, 17(03): 140-145.
[10]	徐烨, 李婧, 刘冉佳, 潘晨, 郭明星, 崔向丽. 2017至2021年中国95家医疗机构肝移植术后免疫抑制剂用药分析[J]. 中华移植杂志(电子版), 2023, 17(03): 134-139.
[11]	龚茂迪, 李涛, 陈伟, 徐述雄. 一例长期口服糖皮质激素患者在经皮肾镜碎石取石术后反复发热的管理经验[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 284-287.
[12]	程庆砾. 免疫抑制剂在肾小球疾病中的合理使用[J]. 中华肾病研究电子杂志, 2023, 12(02): 120-120.
[13]	王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[14]	马强, 李军, 苟丽娟. 重症急性胰腺炎miR-21-3p、RUNX3表达水平及对病情发展程度的预测[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 337-341.
[15]	王迎芝, 张先进, 杨士彦. 益生菌结合早期肠内营养对重症急性胰腺炎患者营养状况、肠黏膜屏障功能及肠内营养耐受性的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(01): 55-58.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Advances in immunosuppression for early severe acute pancreatitis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Advances in immunosuppression for early severe acute pancreatitis